₦ 325,500.00
Test Name: First‑Trimester Down Syndrome Screening
Description: Combines fetal ultrasound (nuchal translucency) with maternal blood markers (e.g. PAPP‑A, free β‑hCG) between 11+0 and 13+6 weeks gestation to estimate risk for trisomy‑21 and trisomy‑18.
Clinical Use: Non‑diagnostic risk assessment identifying ~85‑90% of Down syndrome pregnancies; high‑risk cases referred for diagnostic tests (CVS or amnio).
Timing: 11 to 13 weeks + 6 days; results typically available in ~1 week.
Vendor: SYNLab Nigeria
Address: 9 Egbeyemi Street, Ilupeju, Lagos, Nigeria
Email: info@liveldy.com